相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A Phase II, Randomized, Safety and Immunogenicity Study of a Re-Derived, Live-Attenuated Dengue Virus Vaccine in Healthy Adults
Stephen J. Thomas et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2013)
Human immune responses and potential for vaccine assessment in humanized mice
Ramesh Akkina
CURRENT OPINION IN IMMUNOLOGY (2013)
The Dengue Human Challenge Model: Has the Time Come to Accept This Challenge?
Anna P. Durbin et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
Experimental Dengue Virus Challenge of Human Subjects Previously Vaccinated With Live Attenuated Tetravalent Dengue Vaccines
Wellington Sun et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
A Single Dose of Any of Four Different Live Attenuated Tetravalent Dengue Vaccines Is Safe and Immunogenic in Flavivirus-naive Adults: A Randomized, Double-blind Clinical Trial
Anna P. Durbin et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
An Alphavirus Vector-Based Tetravalent Dengue Vaccine Induces a Rapid and Protective Immune Response in Macaques That Differs Qualitatively from Immunity Induced by Live Virus Infection
Laura J. White et al.
JOURNAL OF VIROLOGY (2013)
Preliminary evaluation of DNA vaccine candidates encoding dengue-2 prM/E and NS1: Their immunity and protective efficacy in mice
Hui Lu et al.
MOLECULAR IMMUNOLOGY (2013)
The global distribution and burden of dengue
Samir Bhatt et al.
NATURE (2013)
Virus-like particles displaying envelope domain III of dengue virus type 2 induce virus-specific antibody response in mice
Upasana Arora et al.
VACCINE (2013)
Economic Cost of Dengue in Puerto Rico
Yara A. Halasa et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2012)
The Economic Burden of Dengue
Duane J. Gubler
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2012)
Nomenclature for Immune Correlates of Protection After Vaccination
Stanley A. Plotkin et al.
CLINICAL INFECTIOUS DISEASES (2012)
Enhanced humoral and HLA-A2-restricted dengue virus-specific T-cell responses in humanized BLT NSG mice
Smita Jaiswal et al.
IMMUNOLOGY (2012)
Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial
Arunee Sabchareon et al.
LANCET (2012)
Alteration of Cytokines and Chemokines During Febrile Episodes Associated With Endothelial Cell Damage and Plasma Leakage in Dengue Hemorrhagic Fever
Punnee Butthep et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2012)
Identification of human neutralizing antibodies that bind to complex epitopes on dengue virions
Ruklanthi de Alwis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
The Structural Basis for Serotype-Specific Neutralization of Dengue Virus by a Human Antibody
Ee Ping Teoh et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Immunogenicity and efficacy of chimeric dengue vaccine (DENVax) formulations in interferon-deficient AG129 mice
Joseph N. Brewoo et al.
VACCINE (2012)
Immunogenicity and safety of tetravalent dengue vaccine in 2-11 year-olds previously vaccinated against yellow fever: Randomized, controlled, phase II study in Piura, Peru
Claudio F. Lanata et al.
VACCINE (2012)
Cost of production of live attenuated dengue vaccines: A case study of the Institut Butantan, Sao Paulo, Brazil
R. T. Mahoney et al.
VACCINE (2012)
A Review of Clinical Trials of Human Papillomavirus Prophylactic Vaccines
John T. Schiller et al.
VACCINE (2012)
A dengue DNA vaccine formulated with Vaxfectin® is well tolerated, and elicits strong neutralizing antibody responses to all four dengue serotypes in New Zealand white rabbits
Kanakatte Raviprakash et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2012)
Immunogenicity and safety of recombinant tetravalent dengue vaccine (CYD-TDV) in individuals aged 2-45 y Phase II randomized controlled trial in Singapore
Yee Sin Leo et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2012)
Dengue: an escalating public health problem in Latin America
Roberto Tapia-Conyer et al.
PAEDIATRICS AND INTERNATIONAL CHILD HEALTH (2012)
The dengue situation in Africa
Fred Were
PAEDIATRICS AND INTERNATIONAL CHILD HEALTH (2012)
Dengue fever and dengue haemorrhagic fever in adolescents and adults
Terapong Tantawichien
PAEDIATRICS AND INTERNATIONAL CHILD HEALTH (2012)
Dengue Virus Infection-Enhancing Activity in Serum Samples with Neutralizing Activity as Determined by Using FcγR-Expressing Cells
Meng Ling Moi et al.
PLOS NEGLECTED TROPICAL DISEASES (2012)
Surveillance of Dengue Fever Virus: A Review of Epidemiological Models and Early Warning Systems
Vanessa Racloz et al.
PLOS NEGLECTED TROPICAL DISEASES (2012)
Chimeric Hepatitis B core antigen virus-like particles displaying the envelope domain III of dengue virus type 2
Upasana Arora et al.
JOURNAL OF NANOBIOTECHNOLOGY (2012)
Sculpting humoral immunity through dengue vaccination to enhance protective immunity
Wayne D. Crill et al.
FRONTIERS IN IMMUNOLOGY (2012)
Efficacy of a Tetravalent Chimeric Dengue Vaccine (DENVax) in Cynomolgus Macaques
Jorge E. Osorio et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2011)
Safety and Immunogenicity of a Tetravalent Live-Attenuated Dengue Vaccine in Flavivirus-Naive Infants
Veerachai Watanaveeradej et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2011)
Priming Effect of Dengue and Yellow Fever Vaccination on the Immunogenicity, Infectivity, and Safety of a Tetravalent Dengue Vaccine in Humans
Ming Qiao et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2011)
Health Economics of Dengue: A Systematic Literature Review and Expert Panel's Assessment
Mark E. Beatty et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2011)
Immune Response to Dengue Virus and Prospects for a Vaccine
Brian R. Murphy et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 29 (2011)
Viral vectors as vaccine platforms: deployment in sight
Christine S. Rollier et al.
CURRENT OPINION IN IMMUNOLOGY (2011)
Dengue: clinical forms and risk groups in a high incidence city in the Southeastern region of Brazil
Ivana Macedo Cardoso et al.
REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL (2011)
Dengue transmission in the Asia-Pacific region: impact of climate change and socio-environmental factors
Shahera Banu et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2011)
Development of DENVax: A chimeric dengue-2 PDK-53-based tetravalent vaccine for protection against dengue fever
Jorge E. Osorio et al.
VACCINE (2011)
Live-attenuated, tetravalent dengue vaccine in children, adolescents and adults in a dengue endemic country: Randomized controlled phase I trial in the Philippines
Rosario Z. Capeding et al.
VACCINE (2011)
A human challenge model for dengue infection reveals a possible protective role for sustained interferon gamma levels during the acute phase of illness
V. J. Gunther et al.
VACCINE (2011)
Evaluation of a prototype dengue-1 DNA vaccine in a Phase 1 clinical trial
Charmagne G. Beckett et al.
VACCINE (2011)
Development and clinical evaluation of multiple investigational monovalent DENV vaccines to identify components for inclusion in a live attenuated tetravalent DENV vaccine
Anna P. Durbin et al.
VACCINE (2011)
The development of recombinant subunit envelope-based against dengue virus induced disease
Beth-Ann G. Coller et al.
VACCINE (2011)
From research to phase III: Preclinical, industrial and clinical development of the Sanofi Pasteur tetravalent dengue vaccine
Bruno Guy et al.
VACCINE (2011)
Antibody-mediated neutralization of flaviviruses: A reductionist view
Kimberly A. Dowd et al.
VIROLOGY (2011)
The Human Antibody Response to Dengue Virus Infection
Wahala M. P. B. Wahala et al.
VIRUSES-BASEL (2011)
Evaluation of the Traditional and Revised WHO Classifications of Dengue Disease Severity
Federico Narvaez et al.
PLOS NEGLECTED TROPICAL DISEASES (2011)
Distinct Humoral and Cellular Immunity Induced by Alternating Prime-boost Vaccination Using Plasmid DNA and Live Viral Vector Vaccines Expressing the E Protein of Dengue Virus Type 2
Junu A. George et al.
Immune Network (2011)
Involvement of the Fc gamma receptor IIA cytoplasmic domain in anti body-dependent enhancement of dengue virus infection
Meng Ling Moi et al.
JOURNAL OF GENERAL VIROLOGY (2010)
A Novel Tetravalent Dengue Vaccine Is Well Tolerated and Immunogenic against All 4 Serotypes in Flavivirus-Naive Adults
Dennis Morrison et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Report of an NIAID workshop on dengue animal models
M. Cristina Cassetti et al.
VACCINE (2010)
Development of a recombinant tetravalent dengue virus vaccine: Innmunogenicity and efficacy studies in mice and monkeys
David E. Clements et al.
VACCINE (2010)
Protection against dengue virus by non-replicating and live attenuated vaccines used together in a prime boost vaccination strategy
Monika Simmons et al.
VIROLOGY (2010)
Consequences of the Expanding Global Distribution of Aedes albopictus for Dengue Virus Transmission
Louis Lambrechts et al.
PLOS NEGLECTED TROPICAL DISEASES (2010)
Phase 1 Trial of the Dengue Virus Type 4 Vaccine Candidate rDEN4Δ30-4995 in Healthy Adult Volunteers
Peter F. Wright et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2009)
T Lymphocyte Responses to Heterologous Secondary Dengue Virus Infections
Alan L. Rothman
IMMUNOLOGY AND PATHOGENESIS OF VIRAL HEMORRHAGIC FEVERS (2009)
Antibodies Determine Virulence in Dengue
Scott B. Halstead
IMMUNOLOGY AND PATHOGENESIS OF VIRAL HEMORRHAGIC FEVERS (2009)
A Mouse Model for Studying Dengue Virus Pathogenesis and Immune Response
Katherine L. Williams et al.
IMMUNOLOGY AND PATHOGENESIS OF VIRAL HEMORRHAGIC FEVERS (2009)
Phase 2 clinical trial of three formulations of tetravalent live-attenuated dengue vaccine in flavivirus-naive adults
Wellington Sun et al.
HUMAN VACCINES (2009)
Essential role of platelet-activating factor receptor in the pathogenesis of Dengue virus infection
Danielle G. Souza et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
An adenovirus type 5 (AdV5) vector encoding an envelope domain III-based tetravalent antigen elicits immune responses against all four dengue viruses in the presence of prior AdV5 immunity
Saima Khanam et al.
VACCINE (2009)
Cross-Reactive Memory CD4+ T Cells Alter the CD8+ T-Cell Response to Heterologous Secondary Dengue Virus Infections in Mice in a Sequence-Specific Manner
Coreen M. Beaumier et al.
VIRAL IMMUNOLOGY (2009)
A Prospective Nested Case-Control Study of Dengue in Infants: Rethinking and Refining the Antibody-Dependent Enhancement Dengue Hemorrhagic Fever Model
Daniel H. Libraty et al.
PLOS MEDICINE (2009)
Structural insights into the mechanisms of antibody-mediated neutralization of flavivirus infection: Implications for vaccine development
Theodore C. Pierson et al.
CELL HOST & MICROBE (2008)
Genetic ancestry and income are associated with dengue hemorrhagic fever in a highly admixed population
Ronald E. Blanton et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2008)
Dengue vaccines for travelers
Annelies Wilder-Smith et al.
EXPERT REVIEW OF VACCINES (2008)
Dengue in Vietnamese Infants—Results of Infection‐Enhancement Assays Correlate with Age‐Related Disease Epidemiology, and Cellular Immune Responses Correlate with Disease Severity
Tran Nguyen Bich Chau et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Neutralizing antibody response variation against dengue 3 strains
Mayling Alvarez et al.
JOURNAL OF MEDICAL VIROLOGY (2008)
A tetravalent dengue vaccine based on a complex adenovirus vector provides significant protection in rhesus monkeys against all four serotypes of dengue virus
Kanakatte Raviprakash et al.
JOURNAL OF VIROLOGY (2008)
Guidelines for plaque-reduction neutralization testing of human antibodies to dengue viruses
John T. Roehrig et al.
VIRAL IMMUNOLOGY (2008)
An immunogenic and protective alphavirus replicon particle-based dengue vaccine overcomes maternal antibody interference in weanling mice
Laura J. White et al.
JOURNAL OF VIROLOGY (2007)
Both virus and tumor necrosis factor alpha are critical for endothelium damage in a mouse model of dengue virus-induced hemorrhage
Hsuen-Chin Chen et al.
JOURNAL OF VIROLOGY (2007)
Monoclonal antibody-mediated enhancement of dengue virus infection in vitro and in vivo and strategies for prevention
Ana P. Goncalvez et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Of cascades and perfect storms: the immunopathogenesis of dengue haemorrhagic fever-dengue shock syndrome (DHF/DSS)
Tikki Pang et al.
IMMUNOLOGY AND CELL BIOLOGY (2007)
Crystal structure of the West Nile virus envelope glycoprotein
Grant E. Nybakken et al.
JOURNAL OF VIROLOGY (2006)
Crystal structure of West Nile virus envelope glycoprotein reveals viral surface epitopes
Ryuta Kanai et al.
JOURNAL OF VIROLOGY (2006)
Murine model for dengue virus-induced lethal disease with increased vascular permeability
Sujan Shresta et al.
JOURNAL OF VIROLOGY (2006)
The live attenuated dengue serotype 1 vaccine rDEN1Δ30 is safe and highly immunogenic in healthy adult volunteers
Anna P. Durbin et al.
HUMAN VACCINES (2006)
Vascular leakage in severe dengue virus infections: A potential role for the nonstructural viral protein NS1 and complement
P Avirutnan et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
An evaluation of dengue type-2 inactivated, recombinant subunit, and live-attenuated vaccine candidates in the rhesus macaque model
JR Putnak et al.
VACCINE (2005)
Liver injury and viremia in mice infected with dengue-2 virus
MV Paes et al.
VIROLOGY (2005)
Dengue virus (DV) enhancing antibody activity in preillness plasma does not predict subsequent disease severity or viremia in secondary DV infection
K Laoprasopwattana et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
rDEN4Δ30, a live attenuated dengue virus type 4 vaccine candidate, is safe, immunogenic, and highly infectious in healthy adult volunteers
AP Durbin et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Variable surface epitopes in the crystal structure of dengue virus type 3 envelope glycoprotein
Y Modis et al.
JOURNAL OF VIROLOGY (2005)
Relationship of preexisting dengue virus (DV) neutralizing antibody levels to viremia and severity of disease in a prospective cohort study of DV infection in Thailand
TP Endy et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
Early activation of natural killer and B cells in response to primary dengue virus infection in A/J mice
S Shresta et al.
VIROLOGY (2004)
Conformational changes of the flavivirus E glycoprotein
Y Zhang et al.
STRUCTURE (2004)
Dengue-specific CD8+ T cells have both protective and pathogenic roles in dengue virus infection
J An et al.
IMMUNOLOGY LETTERS (2004)
Vaccine candidates derived from a novel infectious cDNA clone of an American genotype dengue virus type 2
JE Blaney et al.
BMC INFECTIOUS DISEASES (2004)
Policymakers' views on dengue fever/dengue haemorrhagic fever and the need for dengue vaccines in four southeast Asian countries
D DeRoeck et al.
VACCINE (2003)
Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever
J Mongkolsapaya et al.
NATURE MEDICINE (2003)
A ligand-binding pocket in the dengue virus envelope glycoprotein
Y Modis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Anti-TNF antibody treatment reduces mortality in experimental dengue virus infection
A Atrasheuskaya et al.
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY (2003)
Dengue 2 PDK-53 virus as a chimeric carrier for tetravalent dengue vaccine development
CYH Huang et al.
JOURNAL OF VIROLOGY (2003)
Genetic basis of attenuation of Dengue virus type 4 small plaque mutants with restricted replication in suckling mice and in SCID mice transplanted with human liver cells
JE Blaney et al.
VIROLOGY (2002)
The global emergence/resurgence of arboviral diseases as public health problems
DJ Gubler
ARCHIVES OF MEDICAL RESEARCH (2002)
Dengue-specific T cell responses in peripheral blood mononuclear cells obtained prior to secondary dengue virus infections in Thai schoolchildren
MM Mangada et al.
JOURNAL OF INFECTIOUS DISEASES (2002)
Construction, safety, and immunogenicity in nonhuman primates of a chimeric yellow fever-dengue virus tetravalent vaccine
F Guirakhoo et al.
JOURNAL OF VIROLOGY (2001)
HBV core particles as a carrier for B cell/T cell epitopes
P Pumpens et al.
INTERVIROLOGY (2001)
Recombinant chimeric yellow fever-dengue type 2 virus is immunogenic and protective in nonhuman primates
F Guirakhoo et al.
JOURNAL OF VIROLOGY (2000)
Neurological manifestations of dengue infection
T Solomon et al.
LANCET (2000)
Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity
DW Vaughn et al.
JOURNAL OF INFECTIOUS DISEASES (2000)
分享论文
